Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Kubota, H. Fujiwara, H. Amaike, Kazuhiro Takashima, S. Inada, K. Atsuji, M. Yoshimura, Kunio Matsumoto, Toshikazu Nakamura, H. Yamagishi (2004)
Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effectsCancer Science, 95
P. Kaposi-Novák, Ju-Seog Lee, L. Gómez-Quiroz, C. Coulouarn, V. Factor, S. Thorgeirsson (2006)
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.The Journal of clinical investigation, 116 6
Y. Kitadai (2009)
Cancer-Stromal Cell Interaction and Tumor Angiogenesis in Gastric CancerCancer Microenvironment, 3
O. Wever, M. Mareel (2003)
Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 200
Toshikazu Nakamura, T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, S. Shimizu (1989)
Molecular cloning and expression of human hepatocyte growth factorNature, 342
久場 敬司 (2001)
HGF/NK4,a Four-Kringle Antagonist of Hepatocyte Growth Factor,Is an Angiogenesis Inhibitor that Suppresses Tumor Growth and Metastasis in Mice
C. Schmidt, F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, Carmen Birchmeler (1995)
Scatter factor/hepatocyte growth factor is essential for liver developmentNature, 373
Yi Ren, Brian Cao, S. Law, Yi Xie, Pin-Yin Lee, Leo Cheung, Yongxong Chen, Xin Huang, H. Chan, P. Zhao, J. Luk, G. Woude, J. Wong (2005)
Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell CarcinomasClinical Cancer Research, 11
M. Gerritsen, J. Tomlinson, C. Zlot, M. Ziman, S. Hwang (2003)
Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cellsBritish Journal of Pharmacology, 140
V. Brinkmann, Hu Foroutan, M. Sachs, K. Weidner, W. Birchmeier (1995)
Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cellsThe Journal of Cell Biology, 131
D. Grant, H. Kleinman, I. Goldberg, Mahdu Bhargava, B. Nickoloff, J. Kinsella, P. Polverini, E. Rosen (1993)
Scatter factor induces blood vessel formation in vivo.Proceedings of the National Academy of Sciences of the United States of America, 90
Kunio Matsumoto, Toshikazu Nakamura (2005)
Mechanisms and significance of bifunctional NK4 in cancer treatment.Biochemical and biophysical research communications, 333 2
(2004)
Reconstruction of functionally normal and malignant human breast tissues in mice.Proceedings of the National Academy of Sciences of the United States of America, 101 14
M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, Y. Minamishima, M. Katano, Kunio Matsumoto, Toshikazu Nakamura, Masao Tanaka (2002)
Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 10
Johann Wojta, C. Kaun, J. Breuss, Y. Koshelnick, R. Beckmann, E. Hattey, M. Mildner, W. Weninger, Toshikazu Nakamura, Erwin Tschachler, B. Binder (1999)
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.Laboratory investigation; a journal of technical methods and pathology, 79 4
D. Tomioka, N. Maehara, K. Kuba, K. Mizumoto, Masao Tanaka, Kunio Matsumoto, Toshikazu Nakamura (2001)
Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.Cancer research, 61 20
M. Renzo, M. Olivero, A. Giacomini, H. Porte, E. Chastre, L. Mirossay, B. Nordlinger, S. Bretti, S. Bottardi, S. Giordano (1995)
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 1 2
A. Matsumura, T. Kubota, Hiroaki Taiyoh, H. Fujiwara, K. Okamoto, D. Ichikawa, A. Shiozaki, S. Komatsu, M. Nakanishi, Y. Kuriu, Y. Murayama, H. Ikoma, T. Ochiai, Y. Kokuba, Takahiro Nakamura, Kunio Matsumoto, E. Otsuji (2013)
HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.International journal of oncology, 42 2
K. Pietras, T. Sjöblom, K. Rubin, C. Heldin, A. Ostman (2003)
PDGF receptors as cancer drug targets.Cancer cell, 3 5
M. Renzo, R. Poulsom, M. Olivero, P. Comoglio, N. Lemoine (1995)
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer.Cancer research, 55 5
T. Moriyama, H. Kataoka, R. Hamasuna, K. Yokogami, H. Uehara, H. Kawano, T. Goya, H. Tsubouchi, M. Koono, S. Wakisaka (1998)
Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.Biochemical and biophysical research communications, 249 1
T. Whiteside (2008)
The tumor microenvironment and its role in promoting tumor growthOncogene, 27
A. Mantovani, P. Allavena, A. Sica, F. Balkwill (2008)
Cancer-related inflammationNature, 454
C. Birchmeier, W. Birchmeier, E. Gherardi, G. Woude (2003)
Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 4
G. Dong, Zhong Chen, Zhi-yu Li, N. Yeh, C. Bancroft, C. Waes (2001)
Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.Cancer research, 61 15
Kunio Matsumoto, Toshikazu Nakamura (1996)
Emerging multipotent aspects of hepatocyte growth factor.Journal of biochemistry, 119 4
Kazuhiko Date, Kunio Matsumoto, H. Shimura, Masao Tanaka, Toshikazu Nakamura (1997)
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factorFEBS Letters, 420
Kunio Matsumoto, Kazuhiko Date, H. Shimura, Toshikazu Nakamura (1996)
Acquisition of Invasive Phenotype in Gallbladder Cancer Cells via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth FactorJapanese Journal of Cancer Research : Gann, 87
F. Bussolino, M. Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, P. Comoglio (1992)
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growthThe Journal of Cell Biology, 119
Charles Miller, Lin Lin, A. Casper, J. Lim, Dafydd Thomas, M. Orringer, A. Chang, A. Chambers, T. Giordano, T. Glover, D. Beer (2006)
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinomaOncogene, 25
Takao Nakamura, Kunio Matsumoto, A. Kiritoshi, Yasuo Tano, Toshikazu Nakamura (1997)
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.Cancer research, 57 15
D. Hanahan, J. Folkman (1996)
Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 86
K. Matsumoto, H. Okazaki, T. Nakamura (1992)
Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts.Biochemical and biophysical research communications, 188 1
Hepatocyte growth factor (HGF), acting through the c‑Met receptor, plays an important role in solid tumors. Various malignant cells utilize the biological actions of the HGF/c‑Met pathway for their dissociative, invasive and metastatic behaviors. HGF also binds to the receptor expressed on endothelial cells that stimulates angiogenesis, a process critical to continued growth of solid tumors. It is known that HGF induces in vitro expression of vascular endothelial growth factor (VEGF), a key agonist of tumor angiogenesis. In the present study, we showed using in vitro co-culture system with fibroblasts that VEGF expression of CT26 cells was amplified through tumor-stromal interaction, i.e., the HGF paracrine loop. This action was inhibited by interruption of the HGF paracrine loop by gene transfer of NK4, an HGF antagonist. In in vivo experiments, CT26 tumor growth and angiogenesis were markedly enhanced by fibroblast co-inoculation, while the effect of fibroblasts was not observed in NK4‑expressing CT26 cells. These findings suggest that NK4 exerted potent anti‑angiogenic action via indirectly inhibiting VEGF expression of tumor cells in addition to direct effects on endothelial cells. Thus, the HGF/c‑Met pathway may be a considerable candidate for molecular targeting strategy against tumor angiogenesis.
Oncology Reports – Spandidos Publications
Published: Aug 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.